MRSH holder plans sale of 7,100 shares

A holder of MRSH common stock has filed a notice to potentially sell 7,100 shares through Fidelity Brokerage Services LLC, with an aggregate value of $1,348,946.75, on or after July 28, 2026 on the NYSE.

Rhea-AI Filing Summary

A holder of MRSH common stock has filed a notice to potentially sell 7,100 shares through Fidelity Brokerage Services LLC, with an aggregate value of $1,348,946.75, on or after July 28, 2026 on the NYSE. The shares relate to restricted stock awards received from the issuer as compensation, including 1,717 shares vesting on December 15, 2024 and 5,383 shares vesting on February 28, 2025.

Key Figures

Shares planned for sale: 7,100 shares Aggregate value of planned sale: $1,348,946.75 Proposed sale date: 07/28/2026 +2 more

5 metrics

Shares planned for sale 7,100 shares Common stock to be sold through Fidelity Brokerage Services LLC

Aggregate value of planned sale $1,348,946.75 Market value of 7,100 MRSH common shares

Proposed sale date 07/28/2026 Date on which the MRSH shares may be sold on the NYSE

Restricted stock vesting 1 1,717 shares Restricted stock vesting on 12/15/2024 as compensation

Restricted stock vesting 2 5,383 shares Restricted stock vesting on 02/28/2025 as compensation

Key Terms

Form 144, Restricted Stock Vesting, Compensation

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 12/15/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"1717 | 12/15/2024 | Compensation Common | 02/28/2025"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRSH common shares are planned for sale in this Form 144?

The notice covers a potential sale of 7,100 shares of MRSH common stock. The transaction is planned through Fidelity Brokerage Services LLC with trading on the NYSE.

What is the aggregate value of the MRSH shares covered by this Form 144?

The planned sale has an aggregate value of $1,348,946.75. This figure reflects the total market value of the 7,100 MRSH common shares referenced in the notice.

On what date is the MRSH share sale expected to occur?

The proposed sale date for the MRSH common shares is July 28, 2026. This date marks when the holder may begin selling the 7,100 shares on the NYSE.

How were the MRSH shares in the Form 144 originally acquired?

The MRSH shares derive from restricted stock vesting granted as compensation by the issuer. Vesting events include 1,717 shares on December 15, 2024 and 5,383 shares on February 28, 2025.

Which broker and exchange are involved in the planned MRSH sale?

The holder intends to use Fidelity Brokerage Services LLC as broker and trade MRSH common shares on the NYSE. The notice identifies both the broker and exchange explicitly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/28/2026 - 10:43 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001901227
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MARSH & MCLENNAN COMPANIES, INC.
SEC File Number	001-05998
Address of Issuer	1166 AVENUE OF THE AMERICAS NEW YORK NEW YORK 10036
Phone	2123455000
Name of Person for Whose Account the Securities are To Be Sold	South Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7100	1348946.75	477211268	07/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2024	Restricted Stock Vesting	Issuer			1717	12/15/2024	Compensation
Common	02/28/2025	Restricted Stock Vesting	Issuer			5383	02/28/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin C. South
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)